Verastem, Inc. (VSTM)

NASDAQ: VSTM · IEX Real-Time Price · USD
1.13
-0.03 (-2.59%)
At close: Jul 1, 2022 4:00 PM
1.15
+0.02 (1.77%)
After-hours: Jul 1, 2022 6:51 PM EDT
-2.59%
Market Cap 210.59M
Revenue (ttm) 3.64M
Net Income (ttm) -73.13M
Shares Out 186.36M
EPS (ttm) -0.41
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 2,049,361
Open 1.14
Previous Close 1.16
Day's Range 1.09 - 1.22
52-Week Range 1.00 - 3.96
Beta 0.89
Analysts Buy
Price Target 5.36 (+374.3%)
Earnings Date Aug 1, 2022

About VSTM

Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing drugs for the treatment of cancer. Its product in development includes VS-6766, a dual rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) clamp that blocks MEK kinase activity and the ability of RAF to phosphorylate MEK. The company also engages in developing RAMP 201, an adaptive two-part multicenter, parallel cohort, randomized open label trial to evaluate the efficacy and safety of VS-6766 and in combination wi... [Read more...]

Industry Biotechnology
IPO Date Jan 27, 2012
CEO Brian Stuglik
Employees 48
Stock Exchange NASDAQ
Ticker Symbol VSTM
Full Company Profile

Financial Performance

In 2021, Verastem's revenue was $2.05 million, a decrease of -97.68% compared to the previous year's $88.52 million. Losses were -$71.20 million, 5.13% more than in 2020.

Financial Statements

Analyst Forecast

According to 11 analysts, the average rating for VSTM stock is "Buy." The 12-month stock price forecast is 5.36, which is an increase of 374.34% from the latest price.

Price Target
$5.36
(374.34% upside)
Analyst Consensus: Buy
Stock Forecasts

News

3 Top Penny Stocks to Add to Your July 2022 Watchlist

Here's three penny stocks to watch in July 2022 The post 3 Top Penny Stocks to Add to Your July 2022 Watchlist  appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Other symbols: BOXDIBIO

RBC Says Verastem Interim Analysis In Ovarian Cancer Reinforces Enthusiasm

With the anticipation of a 2Q program update, Verastem Oncology (NASDAQ: VSTM) announced that its interim analysis findings for the RAMP 201 program for recurrent low-grade serous ovarian cancer (LGSOC)...

Verastem Oncology Provides Update on RAMP 201 Study Evaluating VS-6766 ± Defactinib in Low-Grade Serous Ovarian Cancer

BOSTON--(BUSINESS WIRE)--Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for people living with cancer, today announced an update from an interim analy...

Best Penny Stocks to Buy in June 2022? 3 to Watch This Week

Check these penny stocks out for your June watchlist The post Best Penny Stocks to Buy in June 2022? 3 to Watch This Week appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks...

Other symbols: BRQSCEI

7 Cheap Biotech Stocks to Buy Now

These biotech stocks are speculative, but could potentially blow up in the next couple of years with new treatments in the pipelines. The post 7 Cheap Biotech Stocks to Buy Now appeared first on Investo...

Verastem Oncology Awarded Pancreatic Cancer Action Network's First Therapeutic Accelerator Award to Evaluate the Comb...

BOSTON--(BUSINESS WIRE)--Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with cancer, today announced that it has received the first “Ther...

Verastem Oncology Reports First Quarter 2022 Financial Results and Highlights Recent Company Progress

BOSTON--(BUSINESS WIRE)--Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with cancer, today reported financial results for the three month...

3 Penny Stocks to Watch With Above Average Volume Today

Are these high-volume penny stocks on your buy list right now? The post 3 Penny Stocks to Watch With Above Average Volume Today  appeared first on Penny Stocks to Buy, Picks, News and Information | Penn...

Other symbols: AGRICVM

Top Penny Stocks Under $2 to Watch As Inflation Rises

Here are three penny stocks under $2 to watch right now The post Top Penny Stocks Under $2 to Watch As Inflation Rises appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Other symbols: GTESONM

Verastem Oncology Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

BOSTON--(BUSINESS WIRE)--Verastem Oncology (Nasdaq:VSTM), a biopharmaceutical company committed to advancing new medicines for patients with cancer, today announced the grant of stock options to purchas...

Verastem Announces $150M Debt Financing To Support VS-6766, Defactinib Development

Verastem Oncology Inc (NASDAQ: VSTM) entered into a credit facility with Oxford Finance LLC for up to $150 million to primarily support the continued development, commercial preparation, and potential l...

Verastem Oncology Reports Fourth Quarter and Full Year 2021 Financial Results and Highlights Recent Company Progress

BOSTON--(BUSINESS WIRE)--Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with cancer, today reported financial results for the three month...

Verastem Oncology Provides Financial Update to Support Development of VS-6766 and Defactinib in RAS Pathway-Driven Tu...

BOSTON--(BUSINESS WIRE)--Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with cancer, today announced it has entered into a credit facilit...

Verastem Oncology Names Preeminent Oncology Researcher Channing Der, PhD, to its Scientific Advisory Board

BOSTON--(BUSINESS WIRE)--Verastem Oncology (Nasdaq:VSTM), a biopharmaceutical company committed to advancing new medicines for patients battling cancer, today announced that Channing Der, PhD, has been ...

Truist Sees 350% Upside On This Cancer-Focused Biopharma Stock - Read Why

Truist has initiated coverage on Verastem Oncology Inc (NASDAQ: VSTM) with a Buy rating and $6.00 price target, equivalent to approximately 350% upside. Analyst Srikripa Devarakonda notes that trading a...

Verastem Oncology Outlines Key 2022 Strategic Priorities and Upcoming Catalysts for Advancing VS-6766 as a Backbone o...

BOSTON--(BUSINESS WIRE)--Verastem Oncology (Nasdaq:VSTM), a biopharmaceutical company committed to advancing new medicines for patients battling cancer, today outlined key strategic priorities and upcom...

Verastem Oncology to Participate in Upcoming Investor Conferences

BOSTON--(BUSINESS WIRE)--Verastem Oncology (Nasdaq:VSTM), a biopharmaceutical company committed to advancing new medicines for patients battling cancer, today announced that the Company will participate...

Mirati (MRTX), Verastem to Study Cancer Drugs for NSCLC

Mirati Therapeutics (MRTX) partners Verastem Oncology (VSTM) to evaluate adagrasib in combination with VS-6766 in KRASG12C-mutant non-small cell lung cancer.

Other symbols: MRTX

Mirati Therapeutics and Verastem Oncology Partner to Evaluate Adagrasib in Combination with VS-6766 in KRASG12C-Mutan...

SAN DIEGO and BOSTON, Nov. 22, 2021 /PRNewswire/ -- Mirati Therapeutics, Inc. (Nasdaq:MRTX), a clinical-stage targeted oncology company and Verastem Oncology (Nasdaq:VSTM), a biopharmaceutical company c...

Other symbols: MRTX

Verastem Oncology to Present at the Jefferies London Healthcare Conference

BOSTON--(BUSINESS WIRE)--Verastem Oncology (Nasdaq:VSTM), a biopharmaceutical company committed to advancing new medicines for patients battling cancer, today announced that the Company will present at ...

Verastem Oncology Reports Third Quarter 2021 Financial Results and Highlights Recent Company Progress

BOSTON--(BUSINESS WIRE)--Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with cancer, today reported financial results for the three month...

Verastem Oncology Appoints Michelle Robertson to Board of Directors

BOSTON--(BUSINESS WIRE)--Verastem Oncology (Nasdaq:VSTM), a biopharmaceutical company committed to advancing new medicines for patients battling cancer, today announced the appointment of Michelle Rober...

3 Biotech Stocks That Could Make You Filthy Rich

These three low-priced cancer stocks could be grossly undervalued.

Other symbols: ADAPCRVS

Top Penny Stocks To Buy The Dip According To Analysts In September

Analysts say these are penny stocks to buy right now. The post Top Penny Stocks To Buy The Dip According To Analysts In September appeared first on Penny Stocks to Buy, Picks, News and Information | Pen...

Other symbols: DRMANMTRZYNE

Verastem Oncology Appoints Louis J. Denis, M.D.

BOSTON--(BUSINESS WIRE)--Verastem Oncology (Nasdaq:VSTM), a biopharmaceutical company committed to advancing new medicines for patients with cancer, today announced the appointment of Louis J. Denis, M....